Research article · 3 Mar 2025
Conference abstractPublished 2018
Surgical aortic valve replacement remains the gold standard in comparison to transcatheter aortic valve implantation (TAVI)
KASH Cardiac Centre , Saudi Arabia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Surgical AVR is the treatment of choice for patients with symptomatic severe degenerative aortic stenosis, as it offers both symptomatic relief and the potential for improved long-term survival. An increasing number of elderly patients with multiple comorbidities are referred for transcatheter aortic valve implantation (TAVI), partly due to the perceived high risks of surgery. These include in particular patients who have had previous cardiac surgery. The study aim was to compare the outcomes of patients with aortic valve disease. Methods: All patients aged > 76 years that underwent a procedure for severe aortic stenosis with or without coronary revascularization at the authors' institution were included in the study; thus, 308 patients underwent previous cardiac surgery was allocated to TAVI TAVI and 192 underwent previous surgery and subsequently had redo surgery AVR. Patients in the TAVI group were older (mean age 87). Treatment modalities were chosen for individual patients according to their EuroSCORE and had a higher logistic EuroSCORE. Results: A total of 500 patients was discussed ,of these patients, 192 underwent TAVI, 308 of whom had undergone previous cardiac surgery Twenty one patients (10%) died during the procedure in the TAVI group, and 32 (13%) died in the AVR group . Predictors for mortality were: age, female gender and surgical valve replacement .Gradients across the implanted valves at one to three months postoperatively were lower in the TAVI group . Conclusion: Surgical aortic valve replacement remains the 'gold standard' treatment for aortic valve disease.Improved risk stratification in patients with aortic valve disease and re-do cardiac surgery is required .AVR and TAVI will likely be offered to different groups of patients Transcatheter aortic valve implantation is the treatment of choice for symptomatic aortic stenosis in the unacceptably high-risk or inoperable patients, and is a reasonable option for highrisk patients in general.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Cardiovascular Research.
Case report · 21 Feb 2025
Double Trouble-Lignocaine Induced Complete Heart Block in QRBBB-ACS
Research article · 16 Jan 2025
Urinary Sodium Excretion and Frequently Consumed High Sodium Foods by Civil Servants in South West Nigeria
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Cardiovascular Research
- SubjectCardiology
- BylineArticles whose byline prints “AlMasri Hatem”
- BylineArticles whose byline prints “Fatma Ibrahim”
- BylineArticles whose byline prints “Abdalrahman Ali”
